PDCD1andCTLA4polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia-Reference-Cited by-同舟云学术

PDCD1andCTLA4polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia

Published:2018-01-23 Issue:5 Volume:180 Page:705-714
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Kasamatsu Tetsuhiro¹^ORCID,Ino Rumi¹,Takahashi Noriyuki¹,Gotoh Nanami¹,Minato Yusuke²,Takizawa Makiko³,Yokohama Akihiko⁴,Handa Hiroshi³^ORCID,Saitoh Takayuki¹,Tsukamoto Norifumi⁵,Murakami Hirokazu¹

Affiliation:

1. Department of Laboratory Sciences; Gunma University Graduate School of Health Sciences; Maebashi Japan

2. Department of Anatomy and Cell Biology; Hyogo College of Medicine; Maebashi Japan

3. Department of Haematology; Gunma University Graduate School of Medicine; Maebashi Japan

4. Blood Transfusion Service; Gunma University Hospital; Maebashi Japan

5. Oncology Centre; Gunma University Hospital; Maebashi Japan

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15085/fullpdf

Reference31 articles.

1. Cytotoxic T lymphocyte antigen-4 (CTLA-4) A49G polymorphism and autoimmune blood diseases;Aktürk;Turkish Journal of Hematology,2010

2. A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele;Anjos;Journal of Biological Chemistry,2002

3. Soluble programmed death 1 (PD-1) is decreased in patients with immune thrombocytopenia (ITP): potential involvement of PD-1 pathway in ITP immunopathogenesis;Atesoglu;Clinical and Applied Thrombosis/Hemostasis,2016

4. Improved regulatory Tcell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents;Bao;Blood,2010

5. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus;Barreto;European Journal of Human Genetics,2004

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics, treatment, and outcomes of nivolumab induced immune thrombocytopenia;Investigational New Drugs;2024-09-12

2. CTLA-4 silencing could promote anti-tumor effects in hepatocellular;Medical Oncology;2024-07-02

3. FOXO1 Single-Nucleotide Polymorphisms Are Associated with Bleeding Severity and Sensitivity of Glucocorticoid Treatment of Pediatric Immune Thrombocytopenia;DNA and Cell Biology;2024-06-01

4. High dimensional proteomic mapping of bone marrow immune characteristics in immune thrombocytopenia;Science China Life Sciences;2024-04-19

5. Cytotoxic T lymphocyte‐associated antigen‐4 (CTLA-4) gene polymorphisms in a cohort of Egyptian patients with immune thrombocytopenia (ITP);Blood Research;2024-03-01